# Martin Förster

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/martin-forster/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,359 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 60 |
| i10-index | 155 |
| Last Known Institution | University College London Hospitals NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5080195917 |
| ORCID iD | https://orcid.org/0000-0003-3876-7269 |
| Works | 428 |

## Researcher papers

- [Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study](https://scholariq.org/papers/pembrolizumab-versus-methotrexate-docetaxel-or-cetuximab-for-recurrent-or/)
- [Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution](https://scholariq.org/papers/allele-specific-hla-loss-and-immune-escape-in-lung-cancer-evolution/)
- [Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors](https://scholariq.org/papers/fc-optimized-anti-cd25-depletes-tumor-infiltrating-regulatory-t-cells-and/)
- [The evolution of lung cancer and impact of subclonal selection in TRACERx](https://scholariq.org/papers/the-evolution-of-lung-cancer-and-impact-of-subclonal-selection-in-tracerx/)
- [Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma](https://scholariq.org/papers/determinants-of-anti-pd-1-response-and-resistance-in-clear-cell-renal-cell/)
- [The evolution of non-small cell lung cancer metastases in TRACERx](https://scholariq.org/papers/the-evolution-of-non-small-cell-lung-cancer-metastases-in-tracerx/)
- [RETRACTED ARTICLE: Antibodies against endogenous retroviruses promote lung cancer immunotherapy](https://scholariq.org/papers/retracted-article-antibodies-against-endogenous-retroviruses-promote-lung-cancer/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [University College London Hospitals NHS Foundation Trust](https://scholariq.org/institutions/university-college-london-hospitals-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.